192 related articles for article (PubMed ID: 12559195)
1. Modulators of ceramide metabolism sensitize colorectal cancer cells to chemotherapy: a novel treatment strategy.
Litvak DA; Bilchik AJ; Cabot MC
J Gastrointest Surg; 2003 Jan; 7(1):140-148. PubMed ID: 12559195
[TBL] [Abstract][Full Text] [Related]
2. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
Maurer BJ; Melton L; Billups C; Cabot MC; Reynolds CP
J Natl Cancer Inst; 2000 Dec; 92(23):1897-909. PubMed ID: 11106681
[TBL] [Abstract][Full Text] [Related]
3. De novo C16- and C24-ceramide generation contributes to spontaneous neutrophil apoptosis.
Seumois G; Fillet M; Gillet L; Faccinetto C; Desmet C; François C; Dewals B; Oury C; Vanderplasschen A; Lekeux P; Bureau F
J Leukoc Biol; 2007 Jun; 81(6):1477-86. PubMed ID: 17329567
[TBL] [Abstract][Full Text] [Related]
4. Elevation of ceramide within distal neurites inhibits neurite growth in cultured rat sympathetic neurons.
de Chaves EI; Bussière M; Vance DE; Campenot RB; Vance JE
J Biol Chem; 1997 Jan; 272(5):3028-35. PubMed ID: 9006952
[TBL] [Abstract][Full Text] [Related]
5. Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway.
Gramatzki D; Herrmann C; Happold C; Becker KA; Gulbins E; Weller M; Tabatabai G
PLoS One; 2013; 8(5):e63527. PubMed ID: 23667632
[TBL] [Abstract][Full Text] [Related]
6. A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancer.
Madigan JP; Robey RW; Poprawski JE; Huang H; Clarke CJ; Gottesman MM; Cabot MC; Rosenberg DW
Exp Cell Res; 2020 Mar; 388(2):111860. PubMed ID: 31972222
[TBL] [Abstract][Full Text] [Related]
7. Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia.
Watters RJ; Fox TE; Tan SF; Shanmugavelandy S; Choby JE; Broeg K; Liao J; Kester M; Cabot MC; Loughran TP; Liu X
Leuk Lymphoma; 2013 Jun; 54(6):1288-96. PubMed ID: 23181473
[TBL] [Abstract][Full Text] [Related]
8. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
Batra S; Reynolds CP; Maurer BJ
Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
[TBL] [Abstract][Full Text] [Related]
9. Targeting ceramide metabolism--a strategy for overcoming drug resistance.
Senchenkov A; Litvak DA; Cabot MC
J Natl Cancer Inst; 2001 Mar; 93(5):347-57. PubMed ID: 11238696
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of acetic acid-induced gastric ulcer formation in rats by glucosylceramide synthase inhibitors.
Nakashita M; Suzuki H; Miura S; Taki T; Uehara K; Mizushima T; Nagata H; Hibi T
Dig Dis Sci; 2013 Feb; 58(2):354-62. PubMed ID: 22918683
[TBL] [Abstract][Full Text] [Related]
11. N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes.
O'Donnell PH; Guo WX; Reynolds CP; Maurer BJ
Leukemia; 2002 May; 16(5):902-10. PubMed ID: 11986953
[TBL] [Abstract][Full Text] [Related]
12. Increasing intracellular ceramide: an approach that enhances the cytotoxic response in prostate cancer cells.
Wang H; Charles AG; Frankel AJ; Cabot MC
Urology; 2003 May; 61(5):1047-52. PubMed ID: 12736045
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of short-chain ceramide and glucosylceramide on sphingolipids and protein kinase C.
Abe A; Wu D; Shayman JA; Radin NS
Eur J Biochem; 1992 Dec; 210(3):765-73. PubMed ID: 1483461
[TBL] [Abstract][Full Text] [Related]
14. Ceramide metabolism determines glioma cell resistance to chemotherapy.
Dumitru CA; Weller M; Gulbins E
J Cell Physiol; 2009 Dec; 221(3):688-95. PubMed ID: 19711353
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
Kartal Yandım M; Apohan E; Baran Y
Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611
[TBL] [Abstract][Full Text] [Related]
16. Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells.
Tyler A; Johansson A; Karlsson T; Gudey SK; Brännström T; Grankvist K; Behnam-Motlagh P
Exp Cell Res; 2015 Aug; 336(1):23-32. PubMed ID: 26004871
[TBL] [Abstract][Full Text] [Related]
17. RhoA regulates resistance to irinotecan by regulating membrane transporter and apoptosis signaling in colorectal cancer.
Ruihua H; Mengyi Z; Chong Z; Meng Q; Xin M; Qiulin T; Feng B; Ming L
Oncotarget; 2016 Dec; 7(52):87136-87146. PubMed ID: 27888624
[TBL] [Abstract][Full Text] [Related]
18. Ethanol-induced changes in the content of triglycerides, ceramides, and glucosylceramides in cultured neurons.
Saito M; Saito M; Cooper TB; Vadasz C
Alcohol Clin Exp Res; 2005 Aug; 29(8):1374-83. PubMed ID: 16131844
[TBL] [Abstract][Full Text] [Related]
19. Ceramide synthesis correlates with the posttranscriptional regulation of the sterol-regulatory element-binding protein.
Worgall TS; Juliano RA; Seo T; Deckelbaum RJ
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):943-8. PubMed ID: 15132973
[TBL] [Abstract][Full Text] [Related]
20. Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come?
Radin NS
Eur J Biochem; 2001 Jan; 268(2):193-204. PubMed ID: 11168352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
